BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Discontinued
Johnson & Johnson (JNJ) Halts Development Of Botox Rival, Axes Staffers 4/15/2014  More...
Forest Laboratories, Inc. (FRX) To Discontinue NAMENDA® Tablets, Focus On Once-Daily NAMENDA XR® 2/17/2014  More...
Sanofi (France) (SAN.PA) Suffers Another Setback, Ditches Late-Stage Bone Marrow Cancer Drug 11/19/2013  More...
ImmunoGen, Inc. (IMGN) Discontinues Study as Lung Cancer Drug Flops; Stock Crashes -18.97%% at Market Close (November 5, 2013) 11/6/2013  More...
Imprimis Pharmaceuticals (immy) to Shift Focus, Discontinues Impracor Phase 3 Program to Focus on Other Areas 11/6/2013  More...
Ariad Pharmaceuticals, Inc. (ARIA) Discontinues Phase 3 Study of Cancer Drug Iclusig; Shares Decimated, Falls -40.67% at Market Close (October 18, 2013) 10/22/2013  More...
Medivir AB (MVIRb.F), Daewoong Pharmaceutical Co., Ltd. Discontinue Hepatitis B Drug Development 9/6/2013  More...
Medivir AB (MVIRb.F) Makes Strategic Decision to Discontinue its NS5A Inhibitor Program 8/15/2013  More...
Albany Molecular Research, Inc. (AMRI) (AMRI): Bristol-Myers Squibb Company (BMY) Stops Development of Depression Drug 8/14/2013  More...
Isis Pharmaceuticals, Inc. (ISIS) Ditches Rheumatoid Arthritis Drug After Phase 2 Trial Disappoints 8/6/2013  More...
Higher Death Rates Force Celgene Corporation (CELG) to End Blood Cancer Trial 7/22/2013  More...
Roche (RHHBY) Halts Diabetes Drug Trial in Blow to Pipeline 7/12/2013  More...
Roche (RHHBY) Backs Out on Seaside Therapeutics Drug Trial for Fragile X. Parents Dismayed 6/11/2013  More...
Sanofi (France) (SAN.PA) Pulls the Plug on Two Late-Stage Drugs, Plans $285 Million Charge 6/4/2013  More...
Pfizer Inc. (PFE) Halts Study of Non-Hodgkin's Lymphoma Drug 5/29/2013  More...
Merck & Co., Inc. (MRK) Drops Development of Parkinson's Drug 5/28/2013  More...
Eli Lilly and Company (LLY) to Take $30 Million Charge After Cancer Drug Fails Phase 3 Trial 5/15/2013  More...
CytRx Corporation (CYTR) Ditches Lung Cancer Drug After Phase 2 Trial Failure 5/10/2013  More...
Bayer AG (BAY.F) Halts Study of Hemophilia Therapy BAY 86-6150 Due to Safety Concerns 5/7/2013  More...
Celltrion, Inc. Drops Late-Stage Trial of Roche (RHHBY) Rituxan Drug Copy 4/19/2013  More...
Liver Toxicity Brings Melanoma Study on Bristol-Myers Squibb Company (BMY)/Roche (RHHBY) Drugs to a Halt 4/4/2013  More...
Clavis Pharma ASA Stops Elacytarabine Development on Negative Ph3 Trial in AML 4/3/2013  More...
ZIOPHARM Oncology, Inc. (ZIOP.OB) Cancer Drug Fails in Late-Stage Trial; Shares Plunge 3/27/2013  More...
BioLineRx Ltd. Says CLARITY Trial of BL-1020 Did Not Meet Primary Efficacy Endpoint, to Discontinue Study 3/21/2013  More...
Pfizer Inc. (PFE) Halts Development of Hepatitis C Drug 3/19/2013  More...
Moberg Derma Discontinues Clinical Development of Limtop 3/11/2013  More...
AEterna Zentaris (AEZS) to Discontinue Phase 3 Trial in Multiple Myeloma With Perifosine 3/11/2013  More...
FDA Halts Amgen (AMGN) Trial After Teen Death 3/4/2013  More...
Amgen (AMGN), UCB, Inc. (UCBJF.PK) Halt Testing of Fracture-Healing Drug 2/13/2013  More...
Eli Lilly and Company (LLY) to Cease Tabalumab Phase 3 RA Program 2/8/2013  More...
Idenix Pharmaceuticals, Inc. (IDIX) Halts Development of Two Hepatitis C Treatments 2/6/2013  More...
Vanda Pharmaceuticals, Inc. (VNDA) to Stop Developing Anti-Depressant 2/1/2013  More...
What Merck & Co., Inc. (MRK) Told Doctors About Tredaptive Before It Stopped Selling It 1/15/2013  More...
Merck & Co., Inc. (MRK) Pulls Tredaptive Cholesterol Pill After a Flop 1/14/2013  More...
Tranzyme Pharma (TZYM) Stops Mid-Stage Gastric Study After Drug Fails 12/18/2012  More...
Boehringer Ingelheim Corporation Ends Phase 2 Trial of Dabigatran in Mechanical Valve Patients 12/13/2012  More...
Geron Corporation (GERN) Ends Brain Cancer Drug Study, Cuts 43 Jobs 12/10/2012  More...
Bristol-Myers Squibb Company (BMY) Drops Alzheimer's Drug on Little Benefit 12/5/2012  More...
Ranbaxy Laboratories (RANBAXY.BO) Halts Production of Generic Lipitor 12/3/2012  More...
Merck & Co., Inc. (MRK) Shelves Development of Another Diabetes-Cholesterol Program 11/14/2012  More...
Roche (RHHBY)'s Good Cholesterol Drug Shows Negative Side Effects 11/7/2012  More...
Bioniche Life Sciences Inc. (BNC) Discontinues Current Phase 3 Clinical Trial With Urocidin™ 11/5/2012  More...
Ex-Geron Corporation (GERN) CEO Launches Effort to Revive Lost Stem Cell Program 10/29/2012  More...
Abbott Laboratories (ABT), Reata Pharmaceuticals, Inc. Kidney Disease Drug Trial Stopped 10/22/2012  More...
Novartis AG (NVS) Stops Developing Long-Acting Version of Vanda Pharmaceuticals, Inc. (VNDA)'s Fanapt 10/12/2012  More...
Oxford BioMedica PLC (OXB.L) Abandons Prostate Cancer Vaccine Study 10/11/2012  More...
Anacor Pharmaceuticals, Inc. Says GlaxoSmithKline (GSK) Stops Development of Antibiotic 10/8/2012  More...
ArQule, Inc. (ARQL), Daiichi Sankyo, Inc. (4568.t) Discontinue Lung Cancer Drug Trial 10/3/2012  More...
Novo Nordisk A/S (NVO) Halts Development of Hemophilia Drug 10/2/2012  More...
Vertex Pharmaceuticals (MA) (VRTX) Ends Work on One Hepatitis C Drug, Continues Another 9/26/2012  More...
Astex Pharmaceuticals (ASTX) Ends Development of Lung Cancer Drug 9/24/2012  More...
Targacept, Inc. (TRGT) to Cut More Jobs, Halt ADHD Drug Development After Failed Phase 2 Trial 9/18/2012  More...
Johnson & Johnson (JNJ) Ends Trial of Skin-Disorder Drug Over Adverse Events 9/17/2012  More...
Lundbeck Inc. (LUN.CO) Halts Sales of Leukemia Drug Over Supply Problems 9/17/2012  More...
Geron Corporation (GERN) Ends Breast Cancer Study of Imetelstat 9/11/2012  More...
Zalicus Inc. (ZLCS) to Halt Further Clinical Development With Synavive 9/10/2012  More...
Palatin Technologies (PTN) Says Partner AstraZeneca PLC (AZN) to Halt Further Development of Obesity Drug 9/10/2012  More...
Eli Lilly and Company (LLY) Ends Development of Schizophrenia Drug 8/30/2012  More...
Bristol-Myers Squibb Company (BMY) Ends Hepatitis C Development After Patient Death; Eats a $1.8 Billion Loss 8/27/2012  More...
Gilead Sciences, Inc. (GILD) Stops Development of PAH Drug After Missing Study Goal 8/23/2012  More...
Pfizer Inc. (PFE), Johnson & Johnson (JNJ) Scrap Alzheimer's Drug After Phase III Study Fails 8/8/2012  More...
Infinity Pharmaceuticals Inc. (INFI) Pulls Plug on Cancer Drug Saridegib Trials 6/19/2012  More...
BioInvent (BOVNF), ThromboGenics NV (TBGNF) Plunges as Development of Anticoagulent is Dropped 6/5/2012  More...
Chelsea Therapeutics, Inc. (CHTP) Halts Development of Arthritis Drug 6/1/2012  More...
Q-Med AB Discontinues the Breast Indication for Macrolane 4/17/2012  More...
SciClone Pharmaceuticals, Inc. (SCLN) to Discontinue Development of SCV-07 Oral Mucositis Trial 3/7/2012  More...
Karo Bio AB Axes Clinical Dyslipidemia Program After Side Effects Surface in Animal Study 2/15/2012  More...
Theratechnologies Inc. (TH.TO) Cuts 60% of Workforce, Refocus for 2013 12/7/2011  More...
Sanofi (France) (SASY.PA) Discontinues Selling Authorized Generic Version of Lovenox 12/5/2011  More...
National Institutes of Health (NIH) Discontinues Tenofovir Vaginal Gel in 'Voice' HIV Prevention Study 11/29/2011  More...
Celgene International Sárl (CELG) Will Discontinue Phase III MAINSAIL(R) Trial in Castrate-Resistant Prostate Cancer 11/28/2011  More...
Moberg Derma Discontinues Preclinical Development Program for A-Fizz 10/27/2011  More...
Conatus Pharmaceuticals Inc.Terminates Phase 2 Clinical Trial of CTS-1027 10/27/2011  More...
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Drops Europe Development of Insomnia Drug 10/10/2011  More...
Sangamo BioSciences, Inc. (SGMO) Shares Plunge on Diabetic Neuropathy Drug Failure, to Terminate Development 10/4/2011  More...
Astellas Pharma Inc. (YPH.BE) Halts Development of Anti-Clotting Drug 9/29/2011  More...
FDA Issues Clinical Hold on Cancer Drug by Immunomedics, Inc. (IMMU) 9/26/2011  More...
Eisai Inc. (ESALF.PK) Discontinues Global Development of Rabeprazole Sodium Extended-Release Capsules, 50 mg 9/6/2011  More...
Shire plc Falls After Scrapping Dermagraft as Leg Ulcer Therapy 8/25/2011  More...
Endo Pharmaceuticals (ENDP) Terminates Pain Program After Failed Trial; Ends Pact With Grunenthal GmbH 8/19/2011  More...
Amylin Pharmaceuticals, Inc. (AMLN), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Halt Obesity Drug Development Following Commercial Reassessment of the Program 8/8/2011  More...
Merck & Co., Inc. (MRK) to Cut Up to 13,000 Jobs, Q2 Profit Rises; Discontinues Ph3 Migraine Program 8/4/2011  More...
BeiLu Pharma Gives Up on Melatonin-based Depression Drug 7/19/2011  More...
Lack of Partner Prompts Genmab A/S (GEN.CO) to Drop Zalutumumab 6/28/2011  More...
Diamyd Medical AB Discontinues US Phase III Trial with Type I Diabetes Product 6/24/2011  More...
Enzon Pharmaceuticals, Inc. (ENZN) Ditches PEG-SN38 for mCRC but Continues Development in Other Cancers 5/19/2011  More...
Drugmakers Including Johnson & Johnson (JNJ) and Procter & Gamble (PG) Eliminate Infant Drops of Key Medicine 5/5/2011  More...
Pfizer Inc. (PFE) Stops Making Canine Tick Med Over Side Effects 4/25/2011  More...
Galapagos NV (GLPG.BR) Discontinues Phase II Trial for GLPG0259, Focuses Resources on Other Rheumatoid Arthritis Programs 4/15/2011  More...
StemCells Inc. (STEM) Discontinues Batten Disease Program 4/8/2011  More...
AstraZeneca PLC (AZN) Pulls Bloodthinner In France 3/24/2011  More...
AstraZeneca PLC (AZN) Pulls Asthma Product, Hitting SkyePharma Inc. (SKYE) 3/7/2011  More...
Innate Pharma Drops IPH 1101 Development 3/4/2011  More...
Pfizer Inc. (PFE) Drops 15 Pipeline Projects 3/1/2011  More...
Sanofi-Aventis (France) (SASY.PA) to Withdraw Anzemet From Five Countries 2/15/2011  More...
Idenix Pharmaceuticals, Inc. (IDIX) Cancels Hepatitis C Drug On Toxicity Worries; Shares Fall 2/10/2011  More...
Hospira, Inc. (HSP) to Stop Making Drug Used in Executions 1/24/2011  More...
Genentech (RHHBY) Informs Customers of Important Information About Triad Group's Alcohol Prep Pads 1/14/2011  More...
More Evidence Links Roche (RHHBY)'s Avastin to Heart Failure in Breast Cancer Patients 1/6/2011  More...
Ipsen Closes BIM 23A760 Phase II Trials For Acromegaly; Compound Does Not Meet Expectations 12/15/2010  More...
Servier's Diabetes Drug, Mediator May Be Linked to 500 Deaths 11/16/2010  More...
Transition Therapeutics Inc. (TTH.TO) and Eli Lilly and Company (LLY) Stops Diabetes Drug Development 9/17/2010  More...
Basilea Pharmaceutica (BSLN.SW) Announces Discontinuation of Sale of Ceftobiprole by Janssen-Cilag AG, a Johnson & Johnson (JNJ) Company, In Switzerland 9/9/2010  More...
Karo Bio AB Announces That Merck & Co., Inc. (MRK) Discontinues Development of Mk-6913 for Hot Flashes 9/8/2010  More...
Shire Pharmaceuticals (SHPGY) to Pull Low Blood Pressure Drug from Market 8/18/2010  More...
Teva Pharmaceutical Industries Limited (TEVA) Lays Off 70 as Propofol is Abandoned 8/16/2010  More...
Pfizer Inc. (PFE) Pulls Leukemia Drug Mylotarg From U.S. Market After Deaths, No Proven Benefit 6/22/2010  More...
Trubion Pharmaceuticals Inc. (TRBN) Says Pfizer Inc. (PFE) to Stop Development of Arthritis Drug, TRU-015 6/15/2010  More...
Teva Pharmaceutical Industries Limited (TEVA) To Stop Manufacturing Propofol Sedative 5/28/2010  More...
FDA Says Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available 4/14/2010  More...
GenVec Inc. (GNVC) Says Cancer Drug Not Effective, Ends Trial 3/30/2010  More...
Novelos Therapeutics, Inc. (NVLT) Discontinues Current Development Program for NOV-002 in NSCLC; Primary and Secondary Endpoints Not Met in Phase 3 Trial 3/18/2010  More...
Pfizer Inc. (PFE) (JOBS) Drops 100 Drugs from Pipeline 1/29/2010  More...
Pfizer Inc. (PFE) (JOBS) Ends Late-stage Lung-Cancer Study; Analysis Showed it Would Miss Main Goal 12/30/2009  More...
Arena Pharmaceuticals, Inc. (ARNA) Announces Merck KGaA (MKGAF.PK) Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis 12/28/2009  More...
Sanofi-Aventis (France) (SASY.PA) Stops Development of Two Drugs: Eplivanserin in Insomnia and Thrombosis Drug Idrabiotaparinux 12/21/2009  More...
BioMS Medical (MS.TO) Provides Corporate Update; Company will Not Pursue Further Late Stage Clinical Trials with Dirucotide in MS 12/18/2009  More...
Thallion Pharmaceuticals Inc. Discontinues Phase II Glioblastoma Multiforme Trial After Review of Interim Data 12/18/2009  More...
Seattle Genetics, Inc. (SGEN) (JOBS) Stops Mid-Stage Cancer Trial 10/6/2009  More...
SciClone Pharmaceuticals, Inc. (SCLN) (JOBS) Drops Cancer Drug Development 10/5/2009  More...
ZymoGenetics, Inc. (ZGEN) (JOBS) Says Merck Serono Discontinues MS Trials 9/29/2009  More...
Merck & Co., Inc. (MRK) (JOBS) Abandons One Migraine Drug MK-3207, Pursues Another 9/11/2009  More...
Antisoma PLC (ASM.L) Announces Discontinuation of Development of AS1402 8/10/2009  More...
Insmed Incorporated (INSM) Stops Supplying Iplex To New Patients 7/27/2009  More...
Repros Therapeutics Inc. (RPRX) to Stop Using 50 mg Dose in Fibroids Study 7/1/2009  More...
UCB Group (UCBJF.PK) and Biogen Idec, Inc. (Massachusetts) (BIIB) Discontinue Phase II Clinical Trial of CDP323 7/1/2009  More...
Roche Holding AG (RHHBF.PK) Stops Selling Acne Drug Accutane 6/30/2009  More...
ImmunoGen, Inc. (IMGN) to End Stomach-Cancer Drug Development 6/15/2009  More...
Halozyme Therapeutics, Inc. (HALO) Not to Develop Osteoporosis Study Further 6/5/2009  More...
Pfizer Inc. (PFE) (JOBS) Discontinues Late-stage Trial of Sunitinib in Advanced Breast Cancer 6/3/2009  More...
Sanofi-Aventis (France) (SASY.PA) Stops 14 Candidate Drugs, Profit Up 15% 4/29/2009  More...
Targacept, Inc. (TRGT) Provides Update on TC-6499 and Pain Program in GlaxoSmithKline (GSK) Alliance - Data Does Not Support Further Development 3/11/2009  More...
Pfizer Inc. (PFE) Drops Development of 2 Late-Stage Drugs 2/24/2009  More...
Enzon Pharmaceuticals, Inc. (ENZN) Discontinues Further Development of rhMBL 2/10/2009  More...
Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update 1/29/2009  More...
Akesis Pharmaceuticals Discontinues Sole Clinical Development Program and Announces Intent to File for Chapter 7 Bankruptcy 1/22/2009  More...
Nile Therapeutics, Inc. Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program 1/20/2009  More...
Neurobiological Technologies, Inc. (NTII) Ends Stroke Drug Development; Cuts Jobs 1/13/2009  More...
EpiCept Corporation (EPCT) Discontinues Drug Discovery Operations and Reduces Workforce 1/12/2009  More...
Avigen, Inc. (AVGN) Stops Development of Lead Drug; Reduces Headcount by 70% 12/22/2008  More...
SkyePharma Inc. (SKYE) Ceases Commercialization of formoterol Certihaler(R) in the United States 12/19/2008  More...
Adolor Corporation (ADLR) to Stop Development of Bowel Dysfunction Drug 12/18/2008  More...
Solvay Pharmaceuticals, Inc. Ends Research on Cbesity Treatment Compound 11/17/2008  More...
Pfizer Inc. (PFE) (JOBS) Ends Development of Obesity Drug 11/6/2008  More...
Sanofi-Aventis (France) (SASY.PA) Ends Research on Troubled Diet Drug, Accomplia 11/6/2008  More...
Mayo Clinic Cuts Clinical Trial Services Business; Jobs Affected 11/6/2008  More...
ZymoGenetics, Inc. (ZGEN) Kidney Disease Drug Study Stopped 10/28/2008  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) (JOBS) To Discontinue Rheumatoid Arthritis Drug As Drug Fails To Meet Primary, Secondary Endpoints 10/10/2008  More...
Genmab A/S (GNMSF.PK) Announces Discontinuation of Zanolimumab Program and Job Cuts 10/8/2008  More...
Life Science Weekly inSite (Sep. 29 - Oct. 3) 10/6/2008  More...
Merck & Co., Inc. (MRK) (JOBS) Discontinues Development of Investigational Medicine Taranabant for Obesity 10/2/2008  More...
Most Failed Clinical Trials Are Never Published 9/23/2008  More...
Valens Pharma Ltd. Announces Next Steps; Company Has Suspended Work on its DCA i.v Program 8/6/2008  More...
EMD Serono, Inc. to Discontinue Geref Diagnostic 8/5/2008  More...
Ambrilia Biopharma Inc. Provides Update on PPL-100; Merck & Co., Inc. (MRK) (JOBS) Places Development Hold on Drug 7/28/2008  More...
Progen Pharmaceuticals Limited (PGLA) Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 7/24/2008  More...
MethylGene and Celgene (CELG) Announce Precautionary Suspension of New Enrollments Into MGCD0103 Clinical Trials 7/23/2008  More...
National Institute of Allergy And Infectious Diseases (NIAID) Will Not Move Forward with the PAVE 100 HIV Vaccine Trial 7/18/2008  More...
Jury Finds Johnson & Johnson (JNJ) (JOBS) Not Liable in Motrin Lawsuit 7/18/2008  More...
DUSA Pharmaceuticals (DUSA) Announces Update on Nicomide(R); Company Places Voluntary Hold on Existing Inventory 7/18/2008  More...
Infinity Pharmaceuticals, Inc. Discontinues Phase 2 Signal-Finding Clinical Study of IPI-504 in Advanced Prostate Cancer 7/16/2008  More...
BioAlliance Pharma Suspends Phase II/III Trial of Doxorubicin Transdrug(R) in Primary Liver Cancer 7/16/2008  More...
ADVENTRX Pharmaceuticals Inc. (ANX) Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R) 7/1/2008  More...
Novexel Discontinues Development of NXL 101 6/30/2008  More...
Gene-testing Firms Under Fire 6/16/2008  More...
Novo Nordisk A/S (NVO) Discontinues Phase 3 Clinical Trial with NovoSeven(R) in Trauma 6/11/2008  More...
AVI BioPharma, Inc. (AVII) Provides Update on New Business Plan: Discontinues Drug Program, Cuts Jobs 6/10/2008  More...
EXACT Sciences Corporation (EXAS) Reports on Laboratory Corporation of America Holdings (LH)'s Plans to Launch a New Laboratory-developed Stool-based DNA Screening Test for Colorectal Cancer in 2008; LabCorp Stopped Offering PreGen-Plus 6/5/2008  More...
Merck & Co., Inc. (MRK) Ends Study of Cholesterol Drug 5/21/2008  More...
Dynavax Technologies Corporation (DVAX) Ends Development Of Allergy Drug Tolamba After Trial Failure 5/16/2008  More...
Pharmexa A/S (PHARMX.CO) Stops One of Two Phase III Trials 5/13/2008  More...
SGX Pharmaceuticals, Inc. (SGXP) Discontinued Development of SGX523; Announces First Quarter Financial Results 5/13/2008  More...
King Pharmaceuticals®, Inc. Announces Tilade Inhaler to be Discontinued 5/2/2008  More...
NUCRYST Pharmaceuticals Corp. (WEDX) Announces Management Realignment and R&D Portfolio Change; Discontinued Development of NPI 32101 for Inflammatory Bowel Disease (IBD) 5/1/2008  More...
Replidyne, Inc. (RDYN) Discontinues Phase III Trial to Conserve Cash 4/23/2008  More...
Inspire Pharmaceuticals, Inc. (ISPH) to Discontinue Development of Epinastine Nasal Spray 4/23/2008  More...
Synexus' AstraZeneca PLC (AZN)'s Crestor Jupiter Study Stopped Early 4/18/2008  More...
Elan Corporation PLC (ELN), Wyeth (WYE) Suspend Alzheimer's Vaccine Study 4/18/2008  More...
ViroPharma Incorporated (VPHM) and Wyeth Pharmaceuticals End Development of Hepatitis C Drug 4/17/2008  More...
Eisai Company, Ltd. (ESALY.PK) to Drop E2007 Development for Parkinson's Disease 4/11/2008  More...
ArQule, Inc. (ARQL) Provides Clinical Update on E2F-1 Program; Company Plans to Stop Further Clinical Testing 4/10/2008  More...
Pfizer Inc. (PFE) Announces Discontinuation of Phase III Clinical Trial for Patients with Advanced Melanoma 4/2/2008  More...
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Says to Drop Development of Cholesterol Drug 3/28/2008  More...
Keryx Biopharmaceuticals (KERX) Announces Termination of SUN-MACRO Phase 4 Trial 3/28/2008  More...
Sonus Pharmaceuticals, Inc. (SNUS) Ends Discovery Efforts of Two Programs and Reduces its Headcount 3/25/2008  More...
EPIX Pharmaceuticals, Inc. (EPIX) to Stop Clinical Development of Depression Drug 3/20/2008  More...
Nuvelo, Inc. (NUVO) Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 3/18/2008  More...
Genitope Corporation (GTOP) Stops Cancer Vaccine Program, Looking at Finances 3/11/2008  More...
Alkermes (ALKS) Receives Notice from Eli Lilly and Company (LLY) Terminating Inhaled Insulin Program 3/7/2008  More...
Alkermes (ALKS) Provides Update on Inhaled Insulin Program; Eli Lilly and Company (LLY) Expected to Discontinue the Program 3/7/2008  More...
Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Inc., Announces the Discontinuation of the Development Program for Pafuramidine 2/25/2008  More...
Baxter International, Inc. (BAX) Halts Heparin Production Amid Reactions 2/12/2008  More...
Eli Lilly and Company (LLY) Announces Discontinuation of Humatin (Paromomycin Sulfate Capsules, USP) 2/8/2008  More...
Neose Technologies, Inc. (NTEC) Announces Discontinuation of NE-180 Program; Job Cuts 1/30/2008  More...
NMT Medical, Inc (NMTI) Terminates Further Enrollment in MIST II 1/23/2008  More...
Bayer HealthCare Pharmaceuticals (BAY) Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 1/23/2008  More...
Unfavorable Drug Studies Don't Get Into Print: Report 1/17/2008  More...
NitroMed, Inc. (NTMD) Reports on BiDil XR(TM) Progress Following FDA Meeting, Announces Restructuring and Suspension of BiDil(R) Sales Force, and Retains Investment Bank to Advise on Strategic Options 1/16/2008  More...
Novacea, Inc. (NOVC) to Discontinue Cancer Drug Trial 1/3/2008  More...
AstraZeneca LP (AZN) Discontinues LEXXEL (enalapril maleate-felodipine ER) Tablets 12/28/2007  More...